Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database

• Autores principales: Rosanna Ruggiero (Autor), Annamaria Mascolo (Autor), Angela Spezzaferri (Autor), Claudia Carpentieri (Autor), Daniele Torella (Autor), Liberata Sportiello (Autor), Francesco Rossi (Autor), Giuseppe Paolisso (Autor), Annalisa Capuano (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2024-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: A potential risk of suicide associated with liraglutide or semaglutide treatments has recently emerged. Therefore, we decided to investigate the reporting probability of suicidal events among glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Methods: A retrospective pharmacovigilanc...